CAGR of 5.3% Projected for Pertussis Vaccine Market From 2025 to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_
_x000D_
#How Will the Pertussis Vaccine Market Evolve in Terms of Growth and Size by 2029?#_x000D_
The market size of asparaginase for injection has seen a consistent growth over the recent years. The growth rate is anticipated to rise from $2.07 billion in 2024 to $2.16 billion in 2025, marking a compound annual growth rate (CAGR) of 4.3%. The increased growth during the historical period can be ascribed to factors such as enhanced healthcare spending, a heightened focus on treatment of pediatric cancer, vast unmet healthcare needs, the existence of reimbursement plans, a rising trend of cancer cases, improvements in healthcare facilities, and an increased understanding of rare diseases._x000D_
_x000D_
In the forthcoming years, the market size for asparaginase for injection is forecasted to experience substantial growth, escalating to “$2.65 billion in 2029 with a compound annual growth rate (CAGR) of 5.3%.” Factors contributing to this growth during the forecast period include the escalating demand for specialized cancer treatments, an increase in healthcare funding, a surge in pharmaceutical collaborations, an ageing population, a rise in the number of clinical examinations, and the need for precision medicine. Key trends during the forecast period include individualized medicine, integrated therapies with chemotherapy, progress in biotechnology, developments in drug delivery methods, a transition to intravenous formulations, a focus on patient-centered care and the emergence of alternative cancer treatments._x000D_
_x000D_
#Download The Free Sample Report Here:#_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=23319&type=smp_x000D_
_x000D_
#What factors are expected to fuel Pertussis Vaccine market growth in the coming years?#_x000D_
The escalation in birth rates is fueling the expansion of the pertussis vaccine market. Giving birth to a child, also known as childbirth, symbolizes the start of an independent life for the child outside the mother’s womb, after being developed in the uterus. The main usage of the pertussis vaccine is in newborns as it guards against whooping cough and other serious or potentially lethal illnesses. For example, the Centers for Disease Control and Prevention, a national public health organization based in the US, reported in January 2023 that there was a surge of 1% in recorded births, amounting to 3,664,292, compared to the preceding year. Consequently, the surging birth rates are propelling the pertussis vaccine market’s development._x000D_
_x000D_
_x000D_
The asparaginase for injection market covered in this report is segmented – _x000D_
_x000D_
1) By Therapeutic Area: Oncology, Hematology, Neurology, Autoimmune Disorders_x000D_
2) By Formulation Type: Lyophilized Powder, Solution For Injection, Concentrated Solution_x000D_
3) By Route Of Administration: Intravenous, Intramuscular, Subcutaneous_x000D_
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_
5) By Application: Lymphoblastic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin’s Lymphoma_x000D_
_x000D_
Subsegments:_x000D_
1) By Oncology: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Leukemia (including ALL), Lymphoma, Melanoma, Ovarian Cancer_x000D_
2) By Hematology: Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Anemia, Thrombocytopenia, Sickle Cell Disease_x000D_
3) By Neurology: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Migraine, Amyotrophic Lateral Sclerosis (ALS)_x000D_
4) By Autoimmune Disorders: Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Multiple Sclerosis, Crohn’s Disease, Psoriasis, Type 1 Diabetes, Inflammatory Bowel Disease (IBD)_x000D_
_x000D_
#Which Emerging Trends And Strategic Shifts Are Shaping The Pertussis Vaccine Market?#_x000D_
Key players in the asparaginase injection market are turning their focus towards creating cutting-edge products like recombinant medicines for treating acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) patients. These innovative medicines are bio-engineered to mirror natural human substances and produce therapeutic proteins or hormones. In a significant development in July 2023, Jazz Pharmaceuticals, a biopharmaceutical firm from Ireland, gained approval from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for their product JZP458 (recombinant Erwinia asparaginase, also called crisantaspase). This treatment, approved as a component of a multi-agent chemotherapy regimen, offers an alternative therapy for roughly 30% of ALL patients who don’t positively respond to conventional E. coli-derived asparaginase treatments. Clinical studies revealed that JZP458 consistently maintained vital serum asparaginase activity, ensuring its viability as a treatment option._x000D_
_x000D_
#What Are The Most Active Companies In The Pertussis Vaccine Market Today?#_x000D_
Major companies operating in the asparaginase for injection market are Roche, Merck And Co, Bristol-Myers Squibb, Novartis AG, Takeda Pharmaceuticals, Amgen Inc, Intas Pharmaceuticals Ltd, Baxter International, Jazz Pharmaceuticals, Clinigen Ltd , Admac Lifesciences, Hetero Healthcare, G J Pharmaceuticals LLP, Actiza Pharmaceutical Pvt. Ltd., Taj Pharmaceuticals, Sayre Therapeutics, Aark Pharmaceuticals, Bruck Pharma Pvt Ltd, Zymeth Pharmaceuticals Pvt. Ltd., Haematologica, Aetos Pharma _x000D_
_x000D_
_x000D_
_x000D_
#Which Regional Markets Are Attracting The Most Investment In Pertussis Vaccine?#_x000D_
North America was the largest region in the asparaginase for injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asparaginase for injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Request For A Customized Report:#_x000D_
https://www.thebusinessresearchcompany.com/customise?id=23319&type=smp_x000D_
_x000D_
#About The Business Research Company:#_x000D_
_x000D_
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_
_x000D_
#Get in touch with us:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas +1 310-496-7795_x000D_
Asia +44 7882 955267 & +91 8897263534_x000D_
Europe +44 7882 955267_x000D_
Email us at info@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
